Your browser doesn't support javascript.
loading
Long-term maintenance treatment of rosacea: experts' opinion.
Almeida, Luiz M C; Ianhez, Mayra; Dal'Forno, Taciana; Picosse, Fabíola R; Ravelli, Flávia; Kamamoto, Christhine; Sarlos, Priscilla; Gold, Linda F S.
Afiliação
  • Almeida LMC; Department of Dermatology, Santa Casa de Belo Horizonte, Belo Horizonte, Brazil.
  • Ianhez M; Hospital of Tropical Diseases, Universidade Federal de Goiás Faculdade de Medicina, Goiânia, Brazil.
  • Dal'Forno T; Dermatology Residency Program, Pontificia Universidade Catolica do Rio Grande do Sul Porto Alegre, Private Practice, Porto Alegre, Brazil.
  • Picosse FR; Department of Dermatology, Universidade Federal de São Paulo, São Paulo, Brazil.
  • Ravelli F; Private Practice, São Paulo, Brazil.
  • Kamamoto C; Galderma, São Paulo, Brazil.
  • Sarlos P; Private Practice, Rio de Janeiro, Brazil.
  • Gold LFS; Department of Dermatology, Henry Ford Medical Centre, Detroit, MI, USA.
Int J Dermatol ; 63(1): 94-101, 2024 Jan.
Article em En | MEDLINE | ID: mdl-38013632
BACKGROUND: Rosacea is a chronic inflammatory dermatosis characterized by remissions and flares. Although the rosacea active treatment phase is well established, the long-term maintenance phase is still challenging. OBJECTIVE: To discuss and make recommendations on how to treat patients during the long-term maintenance phase for the main rosacea phenotypes. METHODS: A panel of six board-certified Brazilian dermatologists and one American dermatologist gathered to compose a consensus based upon an initial statement on how to treat rosacea during the long-term maintenance phase based on the methodology Nominal Group Technique. The experts discussed each factor based upon an initial statement on how to treat rosacea patients in the long-term maintenance phase. A sequence of comprehensive narrative reviews was performed; a questionnaire preparation about the definition of the maintenance phase and its management was presented; an interpersonal discussion and ranking of the ideas were conducted. Recommendations were made if the specialists had 75% agreement. RESULTS: The maintenance treatment phase, which starts by achieving IGA 0 or 1 grades at the active phase, should be considered at least during the 9-month period after remission. The recommendations of all treatments target this period. Daily skincare regimen and sunscreen are crucial. Active treatment phase should be recommended if signs or symptoms reappear or worsen. CONCLUSION: Maintenance phase success depends on patient's adherence to daily skin care, appropriate treatments, continued follow-up with dermatologist, and self-assessment to identify new signs and symptoms indicating disease relapse.
Assuntos

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Dermatopatias / Rosácea / Dermatite Limite: Humans Idioma: En Revista: Int J Dermatol Ano de publicação: 2024 Tipo de documento: Article País de afiliação: Brasil País de publicação: Reino Unido

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Dermatopatias / Rosácea / Dermatite Limite: Humans Idioma: En Revista: Int J Dermatol Ano de publicação: 2024 Tipo de documento: Article País de afiliação: Brasil País de publicação: Reino Unido